To our knowledge, our results reveal a new mechanism of SDF-1α in pancreatic α-to-β cell transdifferentiation and suggest that miR-23a is a potential biomarker of severe T1D. This evidence concerns the gene CXCL12 and type 1 diabetes mellitus.